Form 4 for TMO Thermo Fisher Scientific
Accepted 2024-10-29 00:00:00 ET · period of report 2024-10-25 · accession 0001127602-24-026058 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-29 | 2024-10-25 | TMO | Boxer Michael A | SVP, GC | M - OptEx | $210.68 | +2,000 | 14.7K | +16% | +$421.4K |
| D | 2024-10-29 | 2024-10-25 | TMO | Boxer Michael A | SVP, GC | S - Sale+OE | $560.16 | -2,000 | 12.7K | -14% | -$1.12M |
| D | 2024-10-29 | 2024-10-25 | TMO | Boxer Michael A | SVP, GC | M - OptEx | $0.00 | -2,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-25 | M | A | 2,000 | $210.68 | 14,735.53 | D | — | — | |
| 2 | Common | Common Stock | 2024-10-25 | S | D | 2,000 | $560.16 | 12,735.53 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-10-25 | M | D | 2,000 | $0.00 | 0 | D | $210.68 · — to 2025-02-27 | 2,000 Common Stock | (F2) The option vested in four equal installments on February 27, 2019, 2020, 2021, and 2022. |